Document is current

Article History

Received: 17 October 2024

Accepted: 15 June 2025

First Online: 30 July 2025

Declarations

:

: The quantitative study components of EVALUNG have been approved by the Ethics Committee of the Hamburg Medical Association (reference number 2022-100917-BO-ff). Informed consent is not required for secondary use of anonymised data from the EVA-LCS. The data protection concept and the associated anonymisation concept have been approved by the responsible data protection officers of the GVS, DGUV and participating UVT. Linkage to cancer registry data is still under development and subject to approval by the relevant committees and authorities. Participation in the qualitative interviews is voluntary for screening-participants and physicians. Informed consent will be obtained in advance. The qualitative study was approved by the Local Psychological Ethics Committee of the Centre for Psychosocial Medicine at the University Medical Centre Hamburg-Eppendorf (reference number LPEK-0589).

: Not applicable.

: VH declares the following COI: He is Director of the Institute for Occupational and Maritime Medicine (ZfAM). In the outpatient clinic of the ZfAM, preventive health care examinations and counselling on LDCT according to EVA-LCS are carried out. As head of the Scientific Advisory Board of EVA-LCS, he is reimbursed for travel and expenses. The other authors declare that they have no competing interests.